Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
| ▸ | ACHE | P22303 | 3/20 | 0.47 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.42 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23850841 | 0.91 | SMN1; SMN2 (0.60) | SMN1; SMN2NPC1HPGDRAB9AACHE | |
| SCHEMBL23850838 | 0.91 | SMN1; SMN2 (0.60) | SMN1; SMN2NPC1HPGDRAB9AACHE | |
| SCHEMBL24323689 | 0.85 | SMN1; SMN2 (0.56) | SMN1; SMN2NPC1HPGDRAB9AACHE | |
| SCHEMBL23852037 | 0.78 | ESR1 (0.60) | SMN1; SMN2NPC1HPGDRAB9AABCB1 | |
| SCHEMBL23852035 | 0.78 | ESR1 (0.60) | SMN1; SMN2NPC1HPGDRAB9AABCB1 | |
| SCHEMBL24322242 | 0.78 | ESR1 (0.60) | SMN1; SMN2NPC1HPGDRAB9AABCB1 | |
| SCHEMBL23851293 | 0.77 | SMN1; SMN2 (0.56) | SMN1; SMN2NPC1HPGDRAB9AACHE | |
| SCHEMBL23851294 | 0.77 | SMN1; SMN2 (0.56) | SMN1; SMN2NPC1HPGDRAB9AACHE | |
| SCHEMBL24322254 | 0.77 | SMN1; SMN2 (0.56) | SMN1; SMN2NPC1HPGDRAB9AACHE | |
| SCHEMBL24322285 | 0.72 | ESR1 (0.58) | SMN1; SMN2NPC1HPGDRAB9AACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220089600-A1 | TGFß INHIBITOR AND PRODRUGS | FUNDACIÓ INSTITUT DE RECERCA BIOMÈDICA (IRB BARCELONA) (ES) | 2022-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220089600-A1 | TGFß INHIBITOR AND PRODRUGS | TGFB1, TGFBR1, TGFBR2 | SMN1; SMN2 2893/4885NPC1 1441/4885HPGD 866/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.